Compare TARS & MANU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TARS | MANU |
|---|---|---|
| Founded | 2016 | 1878 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.6B |
| IPO Year | 2020 | 2012 |
| Metric | TARS | MANU |
|---|---|---|
| Price | $68.26 | $20.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 2 |
| Target Price | ★ $99.80 | $22.96 |
| AVG Volume (30 Days) | ★ 652.8K | 335.1K |
| Earning Date | 11-03-2026 | 12-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 48.21 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $451,360,000.00 | N/A |
| Revenue This Year | $61.17 | $11.71 |
| Revenue Next Year | $26.47 | $6.21 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 146.71 | N/A |
| 52 Week Low | $53.89 | $14.85 |
| 52 Week High | $91.53 | $24.45 |
| Indicator | TARS | MANU |
|---|---|---|
| Relative Strength Index (RSI) | 39.23 | 48.78 |
| Support Level | $60.95 | $20.12 |
| Resistance Level | $74.51 | $21.17 |
| Average True Range (ATR) | 3.34 | 0.46 |
| MACD | -0.37 | 0.07 |
| Stochastic Oscillator | 2.22 | 54.77 |
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.
Manchester United PLC operates as a professional football club with related activities, generating revenue prominently through commercial, broadcasting, and matchday segments. The commercial segment monetizes the various brands via sponsorships, retail, merchandising, apparel, and product licensing. Broadcasting revenue comes from television rights linked to football leagues and competitions, alongside content delivered through its dedicated TV channel all over the globe. Matchday income includes ticket sales, hospitality, merchandise, and services at its stadium. Manchester United is based in England. The company's operations and fan base extend to many countries, supporting a diversified revenue model based on brand engagement and football-related content.